• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Will the results from the AdaptResponse trial boost CRT use?

作者信息

Linde Cecilia

机构信息

Heart, Vascular and Neurology Theme, Karolinska University Hospital, Stockholm, Sweden; Karolinska Institutet, 171 77 Stockholm, Sweden.

出版信息

Lancet. 2023 Sep 30;402(10408):1110-1112. doi: 10.1016/S0140-6736(23)01313-2. Epub 2023 Aug 24.

DOI:10.1016/S0140-6736(23)01313-2
PMID:37634522
Abstract
摘要

相似文献

1
Will the results from the AdaptResponse trial boost CRT use?AdaptResponse试验的结果会促进心脏再同步治疗（CRT）的使用吗？
Lancet. 2023 Sep 30;402(10408):1110-1112. doi: 10.1016/S0140-6736(23)01313-2. Epub 2023 Aug 24.
2
Rationale and design of the AdaptResponse trial: a prospective randomized study of cardiac resynchronization therapy with preferential adaptive left ventricular-only pacing.适应反应试验的原理和设计：心脏再同步治疗中优先适应性左心室单独起搏的前瞻性随机研究。
Eur J Heart Fail. 2017 Jul;19(7):950-957. doi: 10.1002/ejhf.895.
3
Economic implications of adding a novel algorithm to optimize cardiac resynchronization therapy: rationale and design of economic analysis for the AdaptResponse trial.添加新型算法优化心脏再同步治疗的经济学影响：AdaptResponse 试验的经济学分析的原理和设计。
J Med Econ. 2020 Dec;23(12):1401-1408. doi: 10.1080/13696998.2020.1835333. Epub 2020 Oct 28.
4
Quality of life after simultaneously integrated boost with intensity-modulated versus conventional radiotherapy with sequential boost for adjuvant treatment of breast cancer: 2-year results of the multicenter randomized IMRT-MC2 trial.同时整合推量调强与序贯推量常规放疗用于乳腺癌辅助治疗的生活质量：多中心随机 IMRT-MC2 试验的 2 年结果。
Radiother Oncol. 2021 Oct;163:165-176. doi: 10.1016/j.radonc.2021.08.019. Epub 2021 Sep 1.
5
Can increasing the dose of radiation by HDR brachytherapy boost following pre operative chemoradiotherapy for advanced rectal cancer improve surgical outcomes?对于术前放化疗后的局部晚期直肠癌，增加 HDR 近距离放疗的剂量能否改善手术结果？
Colorectal Dis. 2010 Aug;12 Suppl 2:30-6. doi: 10.1111/j.1463-1318.2010.02322.x.
6
Impact of Dose-Escalated Chemoradiation on Quality of Life in Patients With Locally Advanced Rectal Cancer: 2-Year Follow-Up of the Randomized RECTAL-BOOST Trial.局部晚期直肠癌患者调强放疗剂量增加对生活质量的影响：随机RECTAL-BOOST 试验的 2 年随访结果。
Int J Radiat Oncol Biol Phys. 2022 Mar 1;112(3):694-703. doi: 10.1016/j.ijrobp.2021.09.052. Epub 2021 Oct 8.
7
CRT combined with a sequential VMAT boost in the treatment of upper thoracic esophageal cancer.CRT 联合序贯 VMAT 推量在胸上段食管癌治疗中的应用。
J Appl Clin Med Phys. 2013 Sep 6;14(5):153-61. doi: 10.1120/jacmp.v14i5.4325.
8
Intensity Modulated Radiation Therapy (IMRT) With Simultaneously Integrated Boost Shortens Treatment Time and Is Noninferior to Conventional Radiation Therapy Followed by Sequential Boost in Adjuvant Breast Cancer Treatment: Results of a Large Randomized Phase III Trial (IMRT-MC2 Trial).调强放疗（IMRT）同步整合加量与常规放疗序贯加量在辅助乳腺癌治疗中的比较：一项大型随机 III 期临床试验（IMRT-MC2 试验）结果。
Int J Radiat Oncol Biol Phys. 2021 Apr 1;109(5):1311-1324. doi: 10.1016/j.ijrobp.2020.12.005. Epub 2020 Dec 13.
9
Comparison of concomitant boost radiotherapy against concurrent chemoradiation in locally advanced oropharyngeal cancers: a phase III randomised trial.同期加量放疗与同期放化疗治疗局部晚期口咽癌的比较：一项 III 期随机试验。
Radiother Oncol. 2013 Jun;107(3):317-24. doi: 10.1016/j.radonc.2013.05.016. Epub 2013 Jun 6.
10
Preoperative Radiotherapy with a Simultaneous Integrated Boost Compared to Chemoradiotherapy for cT3-4 Rectal Cancer: Long-Term Results of a Multicenter Randomized Study.术前同步整合加量放疗与放化疗治疗cT3-4期直肠癌的比较：一项多中心随机研究的长期结果
Cancers (Basel). 2023 Jul 29;15(15):3869. doi: 10.3390/cancers15153869.

引用本文的文献

1
Sex-related similarities and differences in responses to heart failure therapies.性别相关的心力衰竭治疗反应的相似性和差异性。
Nat Rev Cardiol. 2024 Jul;21(7):498-516. doi: 10.1038/s41569-024-00996-1. Epub 2024 Mar 8.